Skip to content
beroni logo newberoni logo new
  • About
    • About Beroni
    • Our History
    • Board of Directors
    • Management Team
    • Vision, Mission and Values
  • R&D
    • R&D
    • PENAO
      • PENAO Introduction
      • About
      • Board & Senior Management
      • Asset Protection
      • Research & Development​
      • Value Proposition
  • Core Businesses
    • Cell Therapies
    • Anti-Cancer Drugs
    • Infectious Diseases
    • Infectious Diseases – COVID-19
    • E-commerce
  • Products
    • By Beroni China
    • By Beroni USA
    • By Beroni Biotech
  • Investors
    • Announcements
    • Financial Information
    • Corporate Governance
    • Stock Information
    • Globenewswire Press Releases
    • Medtech Outlook
    • Research Report
    • COVID-19 Vaccines Overview
    • FAQs
  • News
  • Contact
  • English
    • 简体中文
Menu Close

Monthly Archives: November 2020

  1. Home>
  2. 2020>
  3. November
Read more about the article Beroni Group Launches a New Probiotics Health Product in China
Beilemei

Beroni Group Launches a New Probiotics Health Product in China

  • Post author:tnt
  • Post published:2020-11-10
  • Post category:2020
  • Post comments:0 Comments

NEW YORK and SYDNEY, November 10, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development,…

Continue ReadingBeroni Group Launches a New Probiotics Health Product in China
Read more about the article Beroni Group Named as a Top Infection Control Solutions Company in APAC for 2020
Certificate

Beroni Group Named as a Top Infection Control Solutions Company in APAC for 2020

  • Post author:tnt
  • Post published:2020-11-10
  • Post category:2020
  • Post comments:0 Comments

NEW YORK and SYDNEY, November 9, 2020 - Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise announced today that the Company has been…

Continue ReadingBeroni Group Named as a Top Infection Control Solutions Company in APAC for 2020

Search Article

Arrange by Year

  • 2017 (10)
  • 2018 (24)
  • 2019 (25)
  • 2020 (17)
  • 2021 (11)
  • 2022 (8)
  • 2023 (5)

What’s New

  • Beroni Pharmaceutical has received approval from the Environmental Impact Report Form of the Zhuhai Ecological Environment Bureau
  • Beroni Group was Invited to Attend the 4th World-Class Enterprises R&D and Innovation Management Forum
  • Successful Conclusion to the Conference of FET
  • Beroni and Shenyang University Of Chemical Technology Successfully Signed the Practice Base Agreement
  • Beroni Group Advances Research and Development of its Enhanced COVID-19 Antigen Rapid Test Kit

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trial, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

  • About Beroni
  • Our History
  • Board of Directors
  • Management Team
  • Vision, Mission, and Values

Core Businesses

  • Cell Therapy
  • Anti-Cancer Drugs
  • Infectious Diseases
  • E-Commerce

Products

  • By Beroni China
  • By Beroni Japan
  • By Beroni USA

Copyrights© Beroni Group 2019 | All rights reserved |

website by chase e-Design

Close Menu